The National Institute of Allergy and Infectious Diseases (NIAID), the Food and Drug Administration (FDA), the Transformational Medical Technologies (TMT), and Biomedical Advanced Research and Development Authority (BARDA) are holding an Animal Model Development Workshop to explore the scientific and regulatory challenges of developing medical countermeasures (MCM) under the "Animal Rule” (21 CFR 314.600 for drugs; 21 CFR 601.90 for biological products).
Federal Register Notice
Final Workshop Agenda
Last Updated September 26, 2012
Last Reviewed September 26, 2012